Rafael Lopez on Muck Rack

Rafael Lopez

Boston
As seen in: Nature, Frontiers, MDPI, Taylor & Francis Online, Patch, KCRG-TV (Cedar Rapids, IA), The Cureus Journal of Medical Science, WOI-TV (Des Moines, IA), The Corsair
Emmy-Nominated Journalist • Bilingual • #NewsJunkie #Globetrotter, #tennis aficionado • Let your talent do the work • @EmersonCollege alum • RTs 🚫endorsements.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Rafael

Contact Rafael, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

High-dimensional reliability analysis of guyed transmission towers via deep learning and progressive collapse simulation

|
By Gabriel Alves, Rafael Lopez, Michael Todd
| Taylor & Francis Online
Abstract This paper presents a reliability assessment of a guyed transmission line tower (TLT) using a high-fidelity progressive collapse model. The simulation captures critical nonlinearities, including geometric and material effects, eccentricities, bolt slippage, and stiffness degradation. Since each evaluation can require up to five days, an active learning framework (AL-SNDGPR) is proposed to make this high-fidelity assessment computationally feasible.
Open in Who Shared Issue with article?

Induction chemo-immunotherapy followed by chemo-radiotherapy and immunotherapy maintenance in stage III NSCLC (APOLO): a phase 2 trial - Nature Communications

|
By Mariano Provencio, Begoña Campos, María Guirado, Laia Vilà, Rosario Garcia Campelo, Miriam Leandro Dorta, Sergio Vázquez Estévez, Asia Ferrández, M. Sala, Ana Ortega, Ana Blasco Verified, Amelia Insa, Maria Areses, Ivana Sullivan, Rafael Lopez, Virginia Calvo, Delvys Rodríguez-Abreu, Joaquim Bosch-Barrera, Ana López-Martín, Raquel Marsé, Laura A. Torrado, Julia Giner, Emilio Sánchez Saugar, Cristina Martinez-Toledo, Atocha Romero, Alberto Cruz-Bermúdez, Kirill Matskov, Manuel Fernández Bruno, Pilar Mediavilla
| Nature Verified
Abstract Unresectable stage III NSCLC standard treatment is chemo-radiotherapy (CT-RT) followed by immunotherapy (IO) with durvalumab. We investigated adding an induction phase with chemo-immunotherapy (ChIO). APOLO was a multicentre, single-arm, phase 2 trial (NCT04776447). Non-resectable stage IIIA–IIIC NSCLC patients received induction ChIO (atezolizumab + carboplatin + paclitaxel, for 3 cycles), followed by concurrent CT-RT (3 cycles), and IO maintenance (atezolizumab for 16 cycles).
Open in Who Shared Issue with article?

Where is Shohei? — The | Corsair

|
By Rafael Lopez
| The Corsair
On March 5, I took a trip to Japan. Before leaving, I joked around with friends saying that Shohei Ohtani, the designated hitter for the Dodgers, would be everywhere. While walking around Tokyo, Ohtani kept on showing up, in the subway, on vending machines, on my hotel TV, and in convenience stores. You couldn't escape from the guy. After the first couple observations, I decided to try to document every new Ohtani I found while in Tokyo.
Open in Who Shared Issue with article?
See all 323 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified